By outfitting immune-system killer cells with a new pair of genes, scientists at Albert Einstein College of Medicine of Yeshiva University transformed them into potent weapons that destroy cells infected with HIV, the virus that causes AIDS.
cientists at Albert Einstein College of Medicine of Yeshiva University have developed a simple, accurate and highly sensitive test to detect and quantify ricin, an extremely potent toxin with potential use as a bioterrorism agent. The report appears as a featured article in the April 12th issue of Analytical Chemistry.
Scientists at Albert Einstein College of Medicine of Yeshiva University have previously shown that the co-mingling of three cell types can predict whether localized breast cancer will spread throughout the body. Now, a collaborative study led by investigators at New York-Presbyterian Hospital/Weill Cornell Medical Center has produced a test for metastasis that could help doctors precisely identify which patients should receive aggressive therapy.
Scientists at Albert Einstein College of Medicine of Yeshiva University have identified genetic markers that signal poor outcomes for patients with head and neck cancer. These findings could one day lead to a genetic test that could help select or predict successful treatment options for patients with this type of cancer. The results were published in the American Journal of Pathology.
A combination of two FDA-approved drugs, already approved for fighting other bacterial infections, shows potential for treating extensively drug resistant tuberculosis (XDR-TB), the most deadly form of the infection. This finding is reported by scientists from Albert Einstein College of Medicine of Yeshiva University in the February 27 issue of Science.
By measuring the activity of four genes in cancer cells, scientists at Albert Einstein College of Medicine accurately predicted whether colorectal tumors are sensitive or resistant to 5-Fluorouracil (5-FU), an important chemotherapy drug.
Mutations in genes governing an important cell-signaling pathway influence human longevity, scientists at Albert Einstein College of Medicine have found. Their research is described in the March 4 issue of the Proceedings of the National Academy of Sciences. The report is the latest finding in the Einstein researchers’ ongoing search for genetic clues to longevity, a study that has recruited more than 450 Ashkenazi (Eastern European) Jews between the ages of 95 and 110.
What do dragons, unicorns, and mermaids have to do with Torah? Rabbi Natan Slifkin, affectionately known as the “Zoo Rabbi,” addressed the subject in a lecture as part of Stern College for Women’s first Torah Umadda Week, February 4-6.
For nearly three decades, Americans have become accustomed to hearing about the latest dietary guidelines, which are required by federal regulation to be revised and reissued at five-year intervals.
In discovering the genes responsible for storing fat in cells, scientists at Albert Einstein College of Medicine have answered one of biology’s most fundamental questions. Their findings, which appear in the December 17 to 21 “Early Edition” online issue of the Proceedings of the National Academy of Sciences, could lead to new strategies for treating obesity and the diseases associated with it.